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Abstract The relevance of the dimeric state for the structure/
function relationships of Rhodotorula gracilis D-amino acid
oxidase (RgDAAO) holoenzyme has been investigated by ra-
tional mutagenesis. Deletion of 14 amino acids in a surface
loop (connecting L-strands 12 and 13) transforms RgDAAO
from a dimeric protein into a stable monomer. The mutant
enzyme is still catalytically competent and retains its binding
with the FAD coenzyme. Dimerization has been used by this
£avoenzyme in evolution to achieve maximal activity, a tighter
interaction between the protein moiety and the coenzyme, and
higher thermal stability. ) 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Many proteins in their native condition are constituted by
more than a single polypeptide chain. We investigated the role
of monomer^monomer interaction by using the enzyme
D-amino acid oxidase (DAAO, EC 1.4.3.3) as a model tool.
The enzyme catalyzes the dehydrogenation of D-amino acids
to the corresponding imino acids, which spontaneously hydro-
lyze to K-keto acids and NHþ4 . The reduced FAD cofactor is
then reoxidized by molecular oxygen. As a result of the wealth
of structural and kinetic information obtained about this en-
zyme (for recent reviews see [1,2]), DAAO has been consid-
ered the prototype for the £avin oxidase class. It contains as a
coenzyme a non-covalently bound molecule of FAD per 40-
kDa protein monomer. The enzyme puri¢ed from the yeast
Rhodotorula gracilis (RgDAAO) shows properties di¡erent
from those of the pig kidney DAAO (pkDAAO), such as a
tight binding of the coenzyme FAD, a high catalytic activity,
and a stable dimeric state in solution (whereas the mammalian
enzyme is present in solution in an oligomerization state de-
pending on the protein concentration) [2]. Crystals of both
pkDAAO and RgDAAO have been obtained, allowing the
resolution of their 3D structure [3,4]. pkDAAO is present in
the crystallographic unit as a dimer [3] ; for it a ‘head-to-head’
interaction of the subunits, resulting in an elongated dimer of
cylindrical shape, was reported [3]. For RgDAAO a mode of
dimerization di¡erent from that of pkDAAO has been pro-
posed in which a ‘head-to-tail’ interaction between the two
monomers yields a spherical dimer (Fig. 1). The buried sur-
face area in RgDAAO is much wider than that observed in
the ‘head-to-head’ dimer of pkDAAO (3049 AA 2 vs. 1512 AA 2 in
yeast and mammalian, respectively) [5]. This wider interaction
area between the two monomers of RgDAAO has been pro-
posed to be mainly due to the presence of a long loop (21
residues, from Pro302 to Glu322) connecting L-strands 12 and
13, near the C-terminus (L12^L13 loop). It has been theoret-
ically calculated that eliminating this loop in the proposed
model halves the interaction area between the two monomers
[5]. This sequence is peculiar to RgDAAO, since it is not
conserved in any of the other known DAAOs (Figs. 2 and
3A,C). The proposed model is supported by previous limited
proteolysis studies: this loop can be easily cleaved o¡ yielding
a monomeric RgDAAO form [6]. The conversion to a mono-
meric form can also be achieved by removing the coenzyme to
yield the corresponding apoprotein form [7].
In order to determine whether the L12^L13 loop plays a
role in the dimerization process and a¡ects the dimer stability
in RgDAAO, a mutant enzyme was designed, produced, and
characterized in which the major part of the L12^L13 loop
(from Ser308 to, and including, Lys321) was deleted.
2. Materials and methods
2.1. Mutagenesis, enzyme expression and puri¢cation, and spectral
characterization
The RgDAAO gene fragment containing the desired mutation was
generated by mutagenic PCR, performed using Taq DNA polymerase
and the cDNA of the RgDAAO wild-type as template. The DNA was
manipulated as described in [8]. A 205-bp fragment of the RgDAAO
wild-type cDNA was ampli¢ed using the BamHI oligonucleotide
(GGCAGAACGGATCGTCCTGCCTCTCGACCGGACAAAGGA-
GAAGGAGGTCACGCTTGTGCATGCGTATGGCGC, 72-mer),
which carries the desired deletion as an upstream primer, and the
SphI oligonucleotide (CGGTCCAGCGGATCCTCAAGCACTGC-
TTGCG, 31-mer) as a downstream primer. To insert the digested
PCR product into the expression vector (pT7.7), the BamHI restric-
tion site of the plasmid was eliminated. The DAAO wild-type cDNA
was inserted into the resulting plasmid using the EcoRI restriction
site, to obtain pT7vBam/Hind-DAAOwt. The PCR product was di-
gested with BamHI and SphI and then cloned into the pT7vBam/
Hind-DAAO vector digested with the same enzymes, obtaining the
pT7-vLOOP plasmid. The presence of the desired deletion was con-
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¢rmed by restriction analysis and DNA sequencing. The plasmid pT7-
vLOOP was used to transform the Escherichia coli BL21(DE3)pLysS
used as an expression strain. The recombinant enzyme was puri¢ed by
a procedure similar to that reported in [9], but replacing hydrophobic
interaction chromatography on the phenyl Sepharose CL-4B column
with cationic exchange chromatography on a Source 15S column in
an Aº KTA system (Amersham Pharmacia Biotech). After chromatog-
raphy on DEAE^Sepharose, precipitation with ammonium sulfate,
and dialysis, the sample was loaded on Source 15S, which was equil-
ibrated with 50 mM MES, pH 6.3, 10% (v/v) glycerol, and 2 mM
EDTA. The bound enzyme was then eluted using the same bu¡er in
the presence of 1 M NaCl and the puri¢ed enzyme concentrated and
desalted using a Sephadex G25 column equilibrated in 50 mM potas-
sium phosphate, pH 7.5, 10% (v/v) glycerol, and 2 mM EDTA. Ab-
sorption spectra of the free enzyme and titration experiments with
various ligands were carried out in the same bu¡er at 15‡C [9]. The
extinction coe⁄cient for the oxidized mutant DAAO was determined
at 15‡C in the same bu¡er without EDTA by measuring the change in
absorbance after release of the £avin by heat denaturation (an extinc-
tion coe⁄cient of 11300 M31 cm31 at 450 nm for free FAD was
used). The apoprotein form of the DAAO-vLOOP mutant was ob-
tained by dialysis in the presence of a chaotrophic agent, as described
in [7].
2.2. Determination of oligomerization state and of isoelectric point
Gel permeation chromatography was carried out using a Superose
12 HR column in an Aº KTA system. The column was equilibrated
with 20 mM potassium phosphate, pH 7.5, 0.25 M NaCl, 10% (v/v)
glycerol, 0.3 mM EDTA, and 5 mM 2-mercaptoethanol. To determine
the molecular mass, a calibration curve was set up using dextran blue
(Mr = 2 000 000) and the following standard proteins: cytochrome c
(Mr = 12 400), carbonic anhydrase (Mr = 29 000), bovine serum albu-
min (Mr = 66 000), alcohol dehydrogenase (Mr = 150 000), L-amylase
(Mr = 200 000). Isoelectrofocusing was carried out in a £at bed appa-
ratus FBE-3000 (Amersham Pharmacia Biotech), using a 6% (w/v)
PAA gel slab containing 2.5% (v/v) of both Pharmalyte0 5-8 and
Pharmalyte0 3-10 (Amersham Pharmacia Biotech). As anodic solu-
tion 1 M H3PO4 was used and as catodic solution 1 M NaOH. The
gel was stained with Coomassie blue R-250.
2.3. Activity assay, thermal and pH stability and pH activity pro¢les
DAAO activity was assayed with an oxygen electrode at 25‡C as
described in [10,11] using 28 mM D-alanine as substrate. To investi-
gate the thermal stability of the DAAO-vLOOP, samples of enzyme
(1.4 WM) were incubated in 50 mM potassium phosphate, pH 7.5, 10%
(v/v) glycerol, and 2 mM EDTA at di¡erent temperatures and the
residual activity was determined at intervals with the polarographic
method as described above. For pH stability, 0.6 WM of mutant
DAAO was incubated at 15‡C in 15 mM Tris^HCl, 15 mM Na2CO3,
15 mM H3PO4, and 250 mM KCl, adjusted at the desired pH value,
and the residual activity was assayed as reported above. Activity at
di¡erent pH values was tested in the same bu¡er as above adjusted at
di¡erent pH values.
2.4. Limited proteolysis experiments
DAAO-vLOOP (0.33 mg/ml) was incubated at 25‡C in 100 mM
sodium pyrophosphate, pH 8, with 10% (w/w) trypsin, and in the
absence or in the presence of 0.2 mM exogenous FAD. For electro-
phoretic analysis, protein samples (7 Wg of DAAO) taken at di¡erent
times after the addition of trypsin were diluted in the sample bu¡er
for SDS^PAGE and boiled for 3 min. Gels were stained with Coo-
massie blue R-250 and the intensity of the protein bands were deter-
mined by densitometric analysis using Image Master 1D (Amersham
Pharmacia Biotech). Kinetic activity was assayed by the same polaro-
graphic method described above, using about 0.3 Wg of DAAO. Ki-
netic data of inactivation and of protein fragment formation and
degradation were ¢tted to either a single or a double exponential
decay equation using KaleidaGraph1 (Sinergy Software).
3. Results
3.1. Design and production of DAAO-vLOOP deletion mutant
The deletion mutant was designed in order to remove a
substantial part of the L12^L13 loop (14 amino acid residues,
from Ser308 to Lys321, Fig. 2). This mutation converts the 21-
residue-long loop into a shorter, 7-residue-long loop (from
Pro302 to Glu308, new numeration, Fig. 2). This mutation
also alters the charge distribution in the interaction area be-
cause of the loss of three positively charged residues (Arg314,
Arg318 and Lys321). A model of the 3D structure of the mu-
tant, named DAAO-vLOOP, was built with the SWISS
MODEL automated protein modeling server [12] on the basis
of the amino acid sequence of the designed mutant and the
3D coordinates of the RgDAAO wild-type (PDB code: 1c0p)
[4]. The conformation of the altered loop was re¢ned using
the software package Swiss-PDBViewer, both by minimizing
the energy as computed by partial implementation of the
GROMOS force ¢eld and by scanning a database of exper-
imentally determined loop structures ([13], URL: http://
www.expasy.ch/spdbc/). This analysis showed that the de-
signed loop is still able to connect the residue Lys307 with
Glu322 (about 4 AA apart) without substantially altering the
overall 3D structure of the protein (Fig. 3B).
For both wild-type and vLOOP DAAOs, the cloning pro-
cedure results in a fusion protein since six additional residues
(Met36-Ala-Arg-Ile-Arg-Leu31) are added at the N-terminus
of the protein before the original starting methionine [9]. In
the 3D structure of RgDAAO only two (Arg32 and Leu31)
out of the six residues of this segment can be modelled into
the electron density map, the remaining four being in a £ex-
ible conformation [4,5]. The presence of this short peptide
does not alter the overall properties of the wild-type
RgDAAO [9]. The DAAO-vLOOP mutant was expressed us-
ing the strain BL21(DE3)pLysS E. coli as host and puri¢ed as
reported in [9] ; however, the hydrophobic interaction chro-
matography step was replaced by cationic exchange chroma-
tography. This modi¢cation of the original procedure was
necessary because, in preliminary experiments, a loss of the
FAD coenzyme from the mutant DAAO-vLOOP was ob-
served during the hydrophobic interaction chromatography
Fig. 1. ‘Head-to-tail’ mode of monomer^monomer interaction of
RgDAAO. The deleted portion of the L12^L13 loop is depicted in
red, the £avin cofactor is in yellow and the substrate D-alanine is in
magenta.
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on phenyl Sepharose. The overall yield of the puri¢cation was
of 40^45%, similar to the yield obtained with other RgDAAO
forms.
The expressed protein possesses a electrophoretic mobility
in SDS^PAGE higher than that of the wild-type RgDAAO,
corresponding to an apparent molecular mass of 40.0W 1.1
kDa (the theoretical value calculated on the basis of the ami-
no acid sequence is 39 334 Da). The isoelectric point of the
mutant was determined under native conditions by isoelectro-
focusing and was compared to the value calculated theoreti-
cally under denaturing conditions by appropriate software
available on the http://www.expasy.ch web site. In both cases,
and as expected for the deletion of an exposed and charged
loop, the pI of the mutant protein was more acidic than that
of the wild-type enzyme (8.8 and 7.6 for wild-type and 8.2 and
6.8 for DAAO-vLOOP under denaturing and native condi-
tions, respectively). This result suggests that the L12^L13 loop
contributes signi¢cantly to the overall surface charge in the
native DAAO.
3.2. Oligomerization state
The oligomerization state of the vLOOP mutant was inves-
tigated by gel-¢ltration chromatography. The elution volume
of DAAO-vLOOP is signi¢cantly di¡erent from that of the
wild-type (14.0 vs. 12.6 ml, respectively, see Fig. 4). From the
elution volume and the calibration curve reported in the inset
of Fig. 4, a molecular mass of 37.2 W 2.2 kDa for the vLOOP
mutant was estimated, to be in good correspondence with the
value determined under denaturing conditions by means of
SDS^PAGE. Deletion of the L12^L13 loop clearly produces
a monomeric holoenzyme. Analogously to wild-type DAAO
[7], the oligomerization state of DAAO-vLOOP mutant is not
dependent on protein concentration, as demonstrated by per-
forming gel-¢ltration chromatography at di¡erent protein
concentrations (0.24, 2.4, and 24 mg/ml).
3.3. FAD and ligands binding, and steady-state kinetics
The puri¢ed DAAO-vLOOP mutant retains the binding of
the FAD coenzyme, as con¢rmed by the absorption spectrum
in the visible region, which is typical of a FAD-containing
protein. The extinction coe⁄cient of the mutant at 455 nm
is lower than that of the wild-type: 11 300 M31 cm31 and
12 600 M31 cm31 [14], respectively. Perturbations in the visi-
ble absorption spectrum indicate changes in the microenviron-
ment surrounding the isoalloxazine moiety of the FAD mol-
ecule. The binding constant for the coenzyme was determined
Fig. 2. Comparison of amino acid sequences of di¡erent DAAOs.
Rg wt, R. gracilis wild-type; Rg vLOOP, R. gracilis vLOOP; Fs,
Fusarium solani ; Tv, Trigonopsis variabilis ; pk, pig kidney; Hum,
man; Rab, rabbit; Mou, mouse. The sequence corresponding to the
L12^L13 loop (residues Pro302^Glu322) of the RgDAAO is under-
lined. The sequence deleted in the mutant DAAO-vLOOP is in
bold.
Fig. 3. Comparison of the structure of the protomer of wild-type
RgDAAO (A) [4], with the model obtained for the DAAO-vLOOP
mutant (B), and with the protomer of wild-type pkDAAO (C) [3].
Arrows indicate the peptide bonds sensible to proteolytic attack
[6].
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by titrating the apoprotein with increasing amounts of FAD
and by monitoring the reconstitution following the quenching
of the FAD £uorescence at 342 nm [7] : a Kd value of the
apoprotein^FAD complex was found to be ¢ve-fold higher
than that of the wild-type RgDAAO (Table 1).
The binding of typical DAAO competitive inhibitors (such
as benzoate, anthranilate, and crotonate) causes changes in
the visible region of the absorption spectrum of the enzyme
[14,15]. The titration of DAAO-vLOOP with these inhibitors
resulted, in all cases, in spectral perturbations similar to those
observed with wild-type DAAO. Dissociation constants were
only slightly di¡erent from those determined for the wild-type
enzyme, indicative of a small e¡ect of the mutation on the
binding between RgDAAO and its active site ligands (Table
1). The vLOOP mutant reacts with sul¢te, producing a cova-
lent adduct: a Kd similar to that observed for wild-type
DAAO was estimated (Table 1), indicating that the deletion
does not a¡ect the overall redox properties of the enzyme.
The steady-state kinetic parameters were determined using
D-alanine (the most frequently used DAAO substrate) and D-
tryptophan (in order to evaluate whether the mutation a¡ects
the ability of the mutant to accommodate a substrate with a
bulky side-chain) as substrates at a ¢xed (21%) oxygen con-
centration. With both substrates, only a slight modi¢cation of
the apparent kinetic parameters is evident. The most signi¢-
cant change is a 1.8-fold decrease in the Vmax value deter-
mined with D-Trp as substrate, and a 1.9-fold increase in
Km for D-Ala (Table 1).
3.4. pH stability and activity and thermal inactivation
Stability and activity pro¢les of DAAO-vLOOP as a func-
tion of pH are similar to those of the wild-type RgDAAO:
both enzymes are stable between pH 6 and 9 and show max-
imum activity at pH 8.5 (data not shown). More pronounced
e¡ects were evident when the thermal stability of the two
DAAO forms was compared. Up to 35‡C, the stability of
the vLOOP mutant holoenzyme lies between that of native
holoenzyme and apoprotein DAAOs [16], whereas at higher
temperatures the mutant enzyme is much less stable: at 40‡C
the vLOOP DAAO holoenzyme retains less then 5% of the
initial activity after 30 min of incubation, as compared to 60%
and 20% observed with wild-type holoenzyme and apoprotein,
respectively.
3.5. Limited proteolysis
Experiments carried out with DAAO puri¢ed from R. gra-
cilis cells demonstrated that three peptide bonds were suscep-
tible to digestion with trypsin: Arg305^Thr306, Arg318^Ala319,
and Arg364^Glu365 [6]. Analysis of the proteolytic products
revealed the formation of a nicked and truncated form of
38.3 kDa, still catalytically competent, in which both the pep-
tide Thr306^Arg318 and the four C-terminal amino acids (Glu-
Ser-Lys-Leu) are cleaved o¡ by trypsin (Scheme 1A). The
activity loss was a biphasic process: the rate of the ¢rst phase
matched the rate of conversion of the intact 40-kDa enzyme
into the 38.3-kDa form, whereas the rate of the second phase
matched the rate of degradation of the 38.3-kDa intermediate
[6].
SDS^PAGE analysis of the time course of trypsinolysis of
DAAO-vLOOP under the same experimental conditions used
for wild-type RgDAAO showed that the deleted mutant is
rapidly converted (more than 95% in less than 1 min) to a
form of 39.0W 1.8 kDa (Fig. 5). Since its N-terminal sequence
is unchanged, appearance of this form is probably due to the
cleavage of the four C-terminal amino acids (Glu-Ser-Lys-
Leu), resulting in a polypeptide with a theoretical molecular
mass of 38 876 Da. At longer incubation times, a band corre-
sponding to a molecular mass of 34.0W 2.1 kDa appeared.
Densitometric analysis of the gel showed that the rate of deg-
radation of the 39-kDa form corresponds to the rate of for-
mation of the 34-kDa form (Table 2). Since the N-terminal
sequence of the 34-kDa form is unchanged, it probably arises
from the cleavage of the Arg305^Ala306 bond, that generates a
polypeptide with a theoretical molecular mass of 33 921 Da.
This digestion pattern is quite di¡erent from that observed
with the wild-type enzyme [6]. In the DAAO-vLOOP the pep-
tide bond Arg305^Thr306, whose cleavage produces the 34-kDa
form (Met1^Arg305) in the RgDAAO wild-type [6], is much
Fig. 4. Gel-permeation chromatography on Superose 12 column of
about 0.4 mg of RgDAAO wild-type (solid line) and of DAAO-
vLOOP (dashed line). Inset: calibration curve of Superose 12 col-
umn; circles: proteins used as gel-¢ltration molecular mass markers;
square: RgDAAO wild-type; triangle: DAAO-vLOOP.
Table 1
Comparison of dissociation constants determined for various ligands and for FAD and of kinetic parameters determined on D-alanine and
D-tryptophan as substrates for wild-type and vLOOP RgDAAO
Enzyme
form
Binding (Kd) D-alanine D-tryptophan
FAD
(WM)
Benzoate
(mM)
Anthranilate
(mM)
Crotonate
(mM)
Sul¢te
(mM)
Vmax (Wmol
O2/min mgenzyme)
Km
(mM)
Vmax (Wmol
O2/min mgenzyme)
Km
(mM)
Wild-type 0.02a 0.9b 1.9b 0.4b 0.12b 110c 0.8c 120c 0.3c
vLOOP 0.1 3.2 W 0.7 2.8W 0.3 0.2 W 0.02 0.08W 0.006 86W 2 1.5W 0.2 68W 2 0.4W 0.05
aFrom [7].
bFrom [15].
cFrom [9].
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less susceptible to trypsinolysis. This observation has also
been con¢rmed by a comparison of the rate constants ob-
served for the degradation of the enzyme’s native form: for
wild-type RgDAAO, this value is about 30-fold higher than
the corresponding rate constant determined for the DAAO-
vLOOP (cf. Table 1 in [6] and Table 2). On the other hand,
the rate constant following complete degradation of the 34-
kDa form is similar for the two enzyme forms. The activity
loss of vLOOP is essentially monophasic, and shows a rate
constant comparable to that of formation of the 34-kDa form
and also to that of its degradation (Table 2). A comparison of
the results obtained by digestion with trypsin on wild-type
and vLOOP DAAOs are summarized in Scheme 1.
However, since the binding between FAD and apoprotein is
weaker in the mutant than in the wild-type RgDAAO, the loss
of activity and the full degradation could be partially ascribed
to the formation of the corresponding apoprotein form. We
previously reported that, in the intact DAAO, the apoprotein
is signi¢cantly more sensitive than the holoenzyme form to
proteolytic attack and to the inactivation because of the in-
creased exposure of the L12^L13 loop to the solvent [6]. As
shown in Table 2, incubation of DAAO-vLOOP with 10%
trypsin in the presence of exogenous FAD (0.2 mM) showed
that the rate of activity loss is lower than that determined in
the absence of exogenous FAD. Although the rate of conver-
sion of the 39-kDa polypeptide into the 34-kDa form was
increased, further degradation of this latter polypeptide,
which is responsible for the complete loss of activity, is de-
creased. This latter result highlights a protecting e¡ect exerted
by the addition of exogenous FAD on the 34-kDa proteolysed
form, due to the maintenance of the mutant DAAO in the
holoenzyme form.
4. Discussion
Limited proteolysis and crystallographic studies suggest
that the long loop connecting L-strands 12 and 13 is involved
in the dimerization of the enzyme [4^6]. A mutant form of
RgDAAO was designed by rational mutagenesis: the region
removed ranges from residues Ser308 to Lys321. The DAAO-
vLOOP mutant was puri¢ed to homogeneity as a monomeric
and active holoenzyme, con¢rming the original hypothesis
that the L12^L13 loop is essential for the dimerization of
the RgDAAO. The monomeric oligomerization state of
DAAO-vLOOP is not dependent on the protein concentra-
tion. The mutant enzyme retains the binding with the FAD
coenzyme, but the interaction between the protein moiety and
the coenzyme is slightly modi¢ed, as indicated by the compar-
ison of the absorption spectrum of the two enzyme forms and
by the increase in the Kd value for the apoprotein^FAD bind-
ing. The ability of the monomeric form of DAAO to bind the
FAD coenzyme con¢rms the observation that in RgDAAO
dimerization follows FAD binding [17]. In addition to the
alteration of FAD binding, even the limited proteolysis ex-
periments point to some conformational changes following
the deletion of the L12^L13 loop, e.g. the Arg305^Thr306 pep-
tide bond becomes signi¢cantly less sensitive to the trypsin
attack. This result indicates signi¢cant and di¡erent confor-
mational changes in this region following conversion to the
monomeric state in the holo- and apoprotein form. In the
dimeric DAAO, the L12^L13 loop is only partially exposed,
since the main part of it is involved in the monomer^mono-
mer interaction. In the monomeric apoprotein the higher ex-
posure of the L12^L13 loop results in an increase in the rate of
Scheme 1. Models for trypsinolysis of wild-type (A) and of vLOOP
(B) RgDAAO. Data for wild-type RgDAAO are from [6]. Number-
ing is referred to that reported in Fig. 1. Note that the puri¢ed
vLOOP mutant contains ¢ve out of the six amino acids of the
N-terminal presequence (Ala-Arg-Ile-Arg-Leu) numbered from 35 to
31.
Fig. 5. SDS^PAGE showing the time course for the tryptic diges-
tion of DAAO-vLOOP in the absence (upper panel) and in the
presence (lower panel) of 0.2 mM exogenous FAD. Each lane con-
tained 7 Wg of DAAO-vLOOP and 0.7 Wg of trypsin (visible as a
band at about 24 kDa). M: molecular mass markers; wt: wild-type
RgDAAO after 2 min of incubation with 10% trypsin in the pres-
ence of 0.2 mM exogenous FAD. The number above each lane cor-
responds to the incubation time expressed in minutes.
Table 2
Rates of inactivation and proteolysis of 0.33 mg/ml DAAO-vLOOP by 10% (w/w) trypsin, at 25‡C and pH 8.0
Exogenous Inactivation (min31U1033) 39-kDa form 34-kDa form
FAD Degradation (min31U1033) Formation (min31U1033) Degradation (min31U1033)
NO 7.8W0.9 4.8W 0.3 6.8 W 0.5 6.9W 0.8
YES 5.8W 0.5 17.2W 5.1 16.7W 3.0 n.d.
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proteolysis with respect to that observed for the dimeric wild-
type holoenzyme [6].
None of the residues involved in the monomer^monomer
interaction is close to the active-site cleft. In fact, DAAO-
vLOOP retains the major part of the catalytic activity of
the wild-type enzyme, as well as its pH stability and activity
optima. The substrate speci¢city of DAAO-vLOOP is essen-
tially unchanged, as well as its ability to bind classical DAAO
inhibitors. These observations indicate that oligomerization is
of no signi¢cance for enzyme function. However, the partial
elimination of the loop a¡ects both the thermal stability of the
enzyme and its maximal activity.
These results provide further support for the role of higher
oligomerization state in thermal stabilization, as recently
showed by studies on triosephosphate isomerase [18]. Interest-
ingly, in the case of RgDAAO, the conversion from a dimeric
to a monomeric oligomerization state does not a¡ect the cat-
alytic competence. This result is di¡erent from that observed
for other oligomeric proteins, e.g. for multimeric dihydro-
neopterin aldolase, where a single amino acid substitution
that disrupts tetramer formation also yields enzyme forms
totally inactive [19]. In conclusion, our results show that it
is possible to design a stable monomeric holoenzyme form
of RgDAAO acting on the length of the L12^L13 loop. The
dimerization is not required to accomplish catalytic activity
and FAD binding, whereas it is a tool to achieve a better
stability and activity of this £avoprotein.
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